Antitumor activity of Notch‑1 inhibition in human colorectal carcinoma cells

Wangdi Liao1, Guohua Li1, Yu You1

  • 1Department of Gastroenterology, The First Affiliated Hospital, Nanchang University, Nanchang, Jiangxi 330006, P.R. China.

Oncology Reports
|December 30, 2017
PubMed

Insights

Notch-1 acts as an oncogene in colorectal cancer. Inhibiting Notch-1 expression and activity significantly reduces tumor cell growth and promotes apoptosis, offering a potential therapeutic strategy for colorectal carcinoma.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • The role of Notch-1 signaling in cancer development is increasingly recognized.
  • Understanding Notch-1's specific function in colorectal carcinoma is crucial for targeted therapies.

Purpose of the Study:

  • To investigate the expression and functional role of Notch-1 in colorectal carcinoma.
  • To explore the potential of targeting Notch-1 for cancer treatment.

Main Methods:

  • Immunohistochemistry was used to detect Notch-1 and Jagged1 expression in various colorectal tissues.
  • Colorectal cancer cell lines were used to confirm Notch-1 expression.
  • Lentiviral-mediated Notch-1 siRNA and the Notch-1 inhibitor DAPT were employed to modulate Notch-1 activity in HT29 cells.

Main Results:

  • Notch-1 and Jagged1 were significantly upregulated in colorectal carcinoma and adenoma tissues compared to normal tissues.
  • Notch-1 was widely expressed in multiple colorectal cancer cell lines.
  • Silencing Notch-1 inhibited cell proliferation, induced G1 cell cycle arrest, and promoted apoptosis in HT29 cells, also increasing P21 and PUMA expression.

Conclusions:

  • Notch-1 functions as an oncogene in colorectal carcinoma.
  • Inhibition of Notch-1 can suppress tumor cell growth and induce apoptosis, suggesting its potential as a therapeutic target in colorectal cancer.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.0K
Feedback Inhibition00:46

Feedback Inhibition

Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
57.4K
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
6.6K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.5K
Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
92.9K
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
17.0K